Should you stop taking Ozempic to participate in the festivities of this holiday season?
University of California, Los Angeles (UCLA), Health Sciences
By monitoring changes in circulating tumor DNA (ctDNA) among 30 patients treated with immunotherapies for metastatic non-small cell lung cancers, researchers were able to determine molecular response — the clearance of tumor genetic material in the bloodstream.
Baylor Scott & White Heart and Vascular Hospital – Dallas has added an innovative, minimally invasive option for patients with hypertension, or high blood pressure.
Non-Hispanic Black patients with acute myeloid leukemia (AML) are living longer, now that new therapies are available, according to a study presented by researchers from the University of Pennsylvania Perelman School of Medicine and Penn Medicine’s Abramson Cancer Center at the 65th American Society of Hematology (ASH) Annual Meeting and Exposition (Abstract 955).
In a study led by researchers at Sylvester Comprehensive Cancer Center, patients recently diagnosed with a common and aggressive form of acute myeloid leukemia reported having improved quality of life when a newly approved drug was part of the treatment plan.
New research conducted by investigators at Sylvester Comprehensive Cancer Center and collaborating cancer centers indicates that a new type of targeted therapy may offer new treatment options for patients living with advanced myelofibrosis, a bone marrow disorder. Study results will be shared at ASH 2023 in San Diego, Dec. 9-12.
تقوم أجسامنا كل يوم ببعض الأمور الغريبة وغير المعتادة. فيما يلي بعض الأسئلة والأجوبة التي تقدم التفسير العلمي وراء حدوث ذلك.
The treatment landscape for acute myeloid leukemia (AML) is evolving rapidly, as research discoveries at Sylvester Comprehensive Cancer Center and other academic cancer centers advance new, more effective therapies for this aggressive blood cancer.
The targeted therapy bezuclastinib was safe and rapidly reduced markers of disease burden while also improving symptoms for patients with a rare blood disorder called nonadvanced system mastocytosis.
Two clinical trials led by researchers from The University of Texas MD Anderson Cancer Center demonstrated early positive results from novel therapies targeting menin for the treatment of relapsed or refractory acute leukemias with specific genetic alterations.
A diario, el cuerpo hace algunas cosas bastante extrañas e inusuales. A continuación, se incluyen algunas preguntas y respuestas que ofrecen la explicación científica de por qué suceden.
Todos os dias, nossos organismos reagem de formas peculiares e incomuns. Aqui estão algumas perguntas e respostas que explicam a base científica desses eventos.
Bioprinted, lab-grown networks of blood vessels in tissue could advance research on a variety of vascular diseases that affect millions of people worldwide, according to Angie Castro, a doctoral student pursuing a degree in chemical engineering at Penn State.
A groundbreaking study by researchers at Case Western Reserve University suggests a class of medications used to treat type 2 diabetes may also reduce the risk of colorectal cancer (CRC).
Patients who received the anticoagulant drug warfarin after bioprosthetic aortic valve replacement had lower incidence of mortality and a decreased risk of blood clots, according to a retrospective study published in Mayo Clinic Proceedings.
Like any typical car or house or society, the pace at which parts of our bodies fall apart varies from part to part.
A study of married or partnered, middle-aged and older heterosexual couples in the U.S., England, China and India found that in 20% to 47% of the couples, both spouses/partners had high blood pressure.
Patients with sickle cell disease (SCD) often face a reduced quality of life and a lower life expectancy. Allotransplantation, the first treatment for SCD with curative potential, comes with risks, including transplant-related mortality. Gene therapy, once approved for SCD, could also offer a lifelong cure without the risk associated with allotransplantation.
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back.
For 30 years, Cheryl Rosenfeld has studied how biological information gets transferred from mothers to babies during pregnancy.
Telemedicine visits for patients with hyperlipidemia — an excess of cholesterol or fats in the blood — experienced similar positive health benefits compared to those who had in-person visits, a study finds. Researchers say telemedicine offers additional options to access treatment that could reduce the risk of cardiovascular disease.
While sugar is the most frequently named culprit in the development of type 2 diabetes, a better understanding of the role of fats is also essential.
In a recent study, scientists led by Professor Stefan Müller from Goethe University’s Institute of Biochemistry II investigated a specific form of blood cancer known as acute myeloid leukemia, or AML. The disease mainly occurs in adulthood and often ends up being fatal for older patients.
Katy Rezvani, M.D., Ph.D., professor of Stem Cell Transplantation & Cellular Therapy at The University of Texas MD Anderson Cancer Center, has been honored with the E. Donnall Thomas Lecture and Prize from the American Society of Hematology (ASH, for her groundbreaking research to develop and advance innovative cell therapies for cancer using natural killer (NK) cells.
Gene expression is often regulated by chemical modifications, a process known as epigenetics for DNA and epitranscriptomics for RNA. Among these, N6-methyladenosine (m6A) is a significant internal modification of mRNA that plays crucial roles in gene expression and various biological and pathological processes, including cancer development.
Researchers at the Wake Forest Institute for Regenerative Medicine (WFIRM) have recently published an article in Nature Communications that demonstrates the potential of bioengineered human placental cells as a cure for Hemophilia A.
SEATTLE — Nov. 30, 2023 — The 65th Annual Meeting & Exposition of the American Society of Hematology (ASH) will take place in San Diego, Calif. and online Dec. 9-13.Below are highlights of Fred Hutchinson Cancer Center research to be presented and experts available to comment on news.
University of Maryland School of Medicine Dean Mark T. Gladwin, MD will join prominent scientists and government health officials this week at a Symposium in Rio De Janeiro, Brazil, to discuss new treatments for sickle cell disease (SCD).
Memorial Sloan Kettering Cancer Center (MSK) and NMDP/Be The Match® today announced the launch of the “American Symphony: Become a Lifesaver” campaign to increase registration of blood stem cell and marrow donors to the national registry and improve access to blood stem cell transplants.
RUDN Laboratory of Biology of Single Cells studied the possibilities of DNA sequencing at the level of individual cells in patients with a rare form of childhood leukemia.
Physicians and scientists from Yale Cancer Center, part of Yale School of Medicine, will present new research at the 65th American Society of Hematology (ASH) Annual Meeting and Exposition in San Diego, Calif., from December 9 to 12. This year’s ASH meeting will include oral and poster presentations, workshops, and educational sessions for hematology professionals.
A research team at The Ohio State University Wexner Medical Center and College of Medicine has been approved for a $14 million award from the Patient-Centered Outcomes Research Institute (PCORI) to study whether a higher daily dose of aspirin is more effective in decreasing the risk of dangerous blood pressure complications among some pregnant people.
Scientists at St. Jude Children’s Research Hospital identified target genes bound and regulated by HOXA9, a protein overexpressed in high-risk leukemia, extending understanding and opening new possibilities for treatment.
Acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS)—two related blood diseases that disproportionally strike older adults—are notoriously difficult to treat and associated with high relapse rates.
Messenger bubbles produced by human cells can pick up bacterial products and deliver them to other cells, University of Connecticut researchers report in the Nov. 16 issue of Nature Cell Biology.
DNA fragments circulating in patients’ blood can reveal the presence of tumors long before CT scans and lead to more agile use of cancer drugs.
Researchers at Washington University School of Medicine in St. Louis have found that a form of cholesterol known as cholesteryl esters builds up in the brains of mice with Alzheimer’s-like disease, and that clearing out the cholesteryl esters helps prevent brain damage and behavioral changes.
Stay informed! Keep up with the latest research on the COVID-19 virus in the Coronavirus channel on Newswise.
In Physics of Fluids, scientists demonstrate how bloodstains can yield valuable details by examining the protrusions that deviate from the boundaries of otherwise elliptical bloodstains. The researchers studied how these “tails” are formed using a series of high-speed experiments with human blood droplets less than a millimeter wide impacting horizontal surfaces at various angles. They found that the tail length can reflect information about the size, impact speed, and impact angle of the blood drop that formed the stain.
Published just before World Diabetes Day, work by Dr. May Faraj, director of the Research Unit on Nutrition, Lipoproteins and Cardiometabolic Diseases at the Montreal Clinical Research Institute (IRCM) and full professor at the Department of Nutrition at the University of Montreal, highlight a new mechanism and a new role for LDL – commonly called bad cholesterol – in the development of type 2 diabetes, LDL already being involved in cardiovascular diseases in the human.
Irvine, Calif., Nov. 20, 2023 — A first-of-its-kind study led by the University of California, Irvine has revealed a new culprit in the formation of brain hemorrhages that does not involve injury to the blood vessels, as previously believed. Researchers discovered that interactions between aged red blood cells and brain capillaries can lead to cerebral microbleeds, offering deeper insights into how they occur and identifying potential new therapeutic targets for treatment and prevention.
Research published in the Journal of Investigative Dermatology provides important insights into skin's defense mechanism against aging and cancer